Radiolabeled Study of CC-220 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 11, 2017

Primary Completion Date

October 16, 2017

Study Completion Date

October 16, 2017

Conditions

Healthy Volunteer

Interventions

DRUG

CC-220

1mg \[14C\]-CC-220 will be administered as a single dose

RADIATION

[14C]

Single dose of \[14C\]-CC-220 will contain approximately 1.4 μCi of radioactivity

Trial Locations (1)

Covance Clinical Research Unit, Madison